OverviewSuggest Edit

SeaSpine is a medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures.
TypePublic
Founded2015
HQCarlsbad, CA, US
Websiteseaspine.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Feb 2019)327
Job Openings43
Revenue (FY, 2020)$154.3 M(-2%)
Share Price (Jun 2021)$20.2
Cybersecurity ratingBMore

Key People/Management at SeaSpine

Keith C. Valentine

Keith C. Valentine

President, Chief Executive Officer and Director
Stuart M. Essig

Stuart M. Essig

Lead Independent Director
John J. Bostjancic

John J. Bostjancic

Senior Vice President, Chief Financial Officer
Keith Bradley

Keith Bradley

Director
Dennis Cirino

Dennis Cirino

Senior Vice President, Spinal Systems
Kimberly Commins-Tzoumakas

Kimberly Commins-Tzoumakas

Director
Show more

SeaSpine Office Locations

SeaSpine has an office in Carlsbad
Carlsbad, CA, US (HQ)
5770 Armada Dr
Show all (1)

SeaSpine Financials and Metrics

SeaSpine Revenue

Embed Graph
View revenue for all periods
SeaSpine's revenue was reported to be $154.35 m in FY, 2020
USD

Revenue (FY, 2020)

154.3m

Gross profit (FY, 2020)

97.5m

Gross profit margin (FY, 2020), %

63.2%

Net income (FY, 2020)

(43.2m)

EBIT (FY, 2020)

(43.4m)

Market capitalization (4-Jun-2021)

668.5m

Closing stock price (4-Jun-2021)

20.2

Cash (31-Dec-2020)

76.8m

EV

606.8m
SeaSpine's current market capitalization is $668.5 m.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

133.2m128.9m131.8m143.4m159.1m154.3m

Revenue growth, %

(3%)

Cost of goods sold

61.1m55.5m51.8m56.0m58.0m56.8m

Gross profit

72.1m73.3m80.0m87.5m101.1m97.5m
Quarterly
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

33.4m14.6m10.8m24.2m20.2m76.8m

Accounts Receivable

11.0m21.9m20.3m24.9m26.2m

Prepaid Expenses

2.0m2.9m3.9m3.9m

Inventories

51.3m45.3m41.7m42.7m47.2m54.0m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(55.5m)(43.2m)(32.1m)(33.5m)(39.3m)(43.2m)

Depreciation and Amortization

12.4m11.8m10.9m10.7m10.3m10.7m

Inventories

(8.4m)1.4m1.2m(3.5m)(5.9m)(10.5m)

Accounts Payable

5.8m(5.0m)(2.1m)1.9m(1.5m)(2.7m)
USDQ2, 2015

Financial Leverage

1.1 x
Show all financial metrics

SeaSpine Operating Metrics

FY, 2016

Patents Issued

3
Show all operating metrics

SeaSpine Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

SeaSpine Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

SeaSpine Online and Social Media Presence

Embed Graph

SeaSpine News and Updates

SeaSpine Announces Closing of 7D Surgical Acquisition

CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical.

SeaSpine to Participate in the Canaccord Genuity Virtual Musculoskeletal Conference

CARLSBAD, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Canaccord Genuity Virtual Musculoskeletal Confer…

SeaSpine Announces Change of Annual Meeting to Virtual Meeting

CARLSBAD, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that, in response to the continued public health concerns regarding in-person ga…

SeaSpine to Report First Quarter 2021 Financial Results on May 3, 2021

CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of tradin…

SeaSpine Announces Limited Commercial Launch of the WaveForm® TO (TLIF Oblique) 3D-Printed Interbody System

CARLSBAD, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TO (TLIF Oblique) Int…

SeaSpine Announces Preliminary Results for First Quarter 2021 and Increases 2021 Revenue Guidance

Provides Additional Financial Guidance for Pending Acquisition of 7D Surgical Provides Additional Financial Guidance for Pending Acquisition of 7D Surgical
Show more

SeaSpine Blogs

SeaSpine® Announces Limited Commercial Launch of the WaveForm® L (Lateral) 3D-Printed Interbody System

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm L (Lateral) Interbody Sys…

SeaSpine® Announces Closing of 7D Surgical Acquisition

CARLSBAD, CA May 20, 2021 – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical. 7D Surgical is a Toronto-based compan…

SeaSpine® to Participate in the Canaccord Genuity Virtual Musculoskeletal Conference

CARLSBAD, Calif., May 10, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Canaccord Genuity Virtual Musculoskeletal Conferenc…

SeaSpine® Announces Change of Annual Meeting to Virtual Meeting

CARLSBAD, Calif., May 07, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that, in response to the continued public health concerns regarding in-person gathe…

SeaSpine® Reports First Quarter 2021 Financial Results

Reaffirms 2021 Financial Outlook CARLSBAD, Calif., May 03, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended March…

SeaSpine® to Report First Quarter 2021 Financial Results on May 3, 2021

CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of trading o…
Show more

SeaSpine Frequently Asked Questions

  • When was SeaSpine founded?

    SeaSpine was founded in 2015.

  • Who are SeaSpine key executives?

    SeaSpine's key executives are Keith C. Valentine, Stuart M. Essig and John J. Bostjancic.

  • How many employees does SeaSpine have?

    SeaSpine has 327 employees.

  • What is SeaSpine revenue?

    Latest SeaSpine annual revenue is $154.3 m.

  • What is SeaSpine revenue per employee?

    Latest SeaSpine revenue per employee is $472 k.

  • Who are SeaSpine competitors?

    Competitors of SeaSpine include ACell, Spinal Elements and Glaukos.

  • Where is SeaSpine headquarters?

    SeaSpine headquarters is located at 5770 Armada Dr, Carlsbad.

  • Where are SeaSpine offices?

    SeaSpine has an office in Carlsbad.

  • How many offices does SeaSpine have?

    SeaSpine has 1 office.